Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€18.78
-€0.72(-3.46%)
At close: 4:00 PM EST
€18.78
-€0.72(-3.46%)
Day’s Range― - ―
52-Week Range€16.16 - €21.96
Previous CloseN/A
Volume184.39K
Average Volume (3M)126.91K
Market Cap
€1.18B
Enterprise Value€1.50K
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€481.10M
Price to Earnings (P/E)15.9
Beta0.88
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.5%
Share Statistics
EPS (TTM)1.29
Shares Outstanding58,250,310
10 Day Avg. Volume117,838
30 Day Avg. Volume126,914
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.83Price Target Upside26.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.35
Revenue Forecast (FY)€1.27B
Bulls Say, Bears Say
Bulls Say
Leverage ReductionMaterial debt reduction versus 2022–2023 meaningfully lowers balance-sheet risk and increases financial flexibility. Sustained lower leverage supports investment capacity, reduces interest burden sensitivity, and strengthens the company's ability to fund operations or M&A over the medium term.
Consistent Cash GenerationStable positive operating cash flow and a multi-year recovery to positive free cash flow indicate improving cash conversion and discipline. This durable cash generation supports reinvestment, dividend capacity and debt paydown, improving resilience through industry cycles.
Improving Operating ProfitabilityHigher EBIT and EBITDA in 2025 suggest better margin control and operational leverage despite revenue softness. Coupled with a product focus on sustainable bio-based ingredients, improved margins point to structural cost or mix improvements that can sustain earnings quality longer term.
Bears Say
Multi-year Revenue SofteningPersistent revenue declines over several years signal demand headwinds or market share pressure in core segments. Without clear top-line recovery, margin gains and cash improvements may be harder to sustain, constraining long-term growth and strategic reinvestment capacity.
Inconsistent Net IncomeEarnings volatility across recent years suggests reliance on one-offs, cyclical swings, or unstable pricing/mix. Inconsistent net income reduces predictability of returns, complicates capital allocation decisions, and raises execution risk for sustaining dividend and investment policies.
Shrinking Asset BaseA notable reduction in total assets indicates contraction in scale or divestments, which can limit growth runway and economies of scale. If asset declines reflect reduced capacity or lost business, long-term revenue and return expansion may be constrained absent new investments.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €16.16 and its highest was €21.96 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.18B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Aug 13, 2026 which is in 28 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Feb 26, 2026. The company reported €0.56 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Annually dividend of €1 which represents an annual dividend yield of 3.5%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.56 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.063%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. It operates through the following segments: Food and Biochemicals. The Food segment provides biobased ingredients for the food industry. The Biochemicals segment produces chemicals derived from organic acids through the fermentation of carbohydrates, and lactic acid based solutions. The company was founded on August 21, 1919 and is headquartered in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€23.83
▲(26.91% Upside)